Latanoprost Zonder Conserveermiddel Stulln

Latanoprost, the active ingredient in Latanoprost Zonder Conserveermiddel Stulln, is a prostaglandin analog presented as eye drops for ocular use. It lowers intra‑ocular pressure and is used to treat primary open‑angle glaucoma and ocular hypertension in adults. It is indicated for patients who require long‑term reduction of intra‑ocular pressure to prevent optic nerve damage.

GNH USA supplies Latanoprost Zonder Conserveermiddel Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable supply chains to meet global demand.

Latanoprost is a prostaglandin analog used to lower intra‑ocular pressure in glaucoma and ocular hypertension. - Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers pressure to prevent development of glaucoma. - Glaucoma (any type): helps reduce pressure across glaucoma subtypes.

Common Side Effects: - Eye redness: mild conjunctival hyperemia after administration. - Increased eyelash growth: longer, thicker lashes may develop. - Darkening of iris: gradual pigmentation change, usually irreversible. - Eye irritation or itching: transient discomfort on instillation.

Serious or Rare Side Effects: - Paradoxical increase in intra‑ocular pressure. - Corneal edema or clouding. - Uveitis or intra‑ocular inflammation. - Severe eye pain or vision loss. - Allergic reaction: swelling, rash, or severe irritation.

Before using Latanoprost, consider the following precautions: - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown safety; weigh potential risks versus benefits. - Contraindications: known hypersensitivity to latanoprost or any excipient. - Monitoring: regular intra‑ocular pressure checks are essential. - Contact lens use: may cause deposits; remove lenses before application. - Store at room temperature: keep bottle in original packaging, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use of other prostaglandin analog eye drops may cause additive hypotensive effect. - Non‑steroidal anti‑inflammatory eye drops can reduce latanoprost efficacy. - Systemic prostaglandin inhibitors may interfere with the drug’s action.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: monitor intra‑ocular pressure for additive effect. - Carbonic anhydrase inhibitor eye drops: potential additive pressure‑lowering. - Systemic antihypertensives: generally safe but monitor ocular response.